SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-249235
Filing Date
2022-09-22
Accepted
2022-09-22 16:38:57
Documents
17
Period of Report
2022-09-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d367672d8k.htm   iXBRL 8-K 39818
2 EX-4.1 d367672dex41.htm EX-4.1 62141
3 EX-10.1 d367672dex101.htm EX-10.1 215158
4 EX-10.2 d367672dex102.htm EX-10.2 88531
5 EX-99.1 d367672dex991.htm EX-99.1 11617
9 GRAPHIC g367672dsp_77.jpg GRAPHIC 2756
  Complete submission text file 0001193125-22-249235.txt   651231

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA aadi-20220922.xsd EX-101.SCH 2849
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE aadi-20220922_lab.xml EX-101.LAB 18739
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aadi-20220922_pre.xml EX-101.PRE 11703
11 EXTRACTED XBRL INSTANCE DOCUMENT d367672d8k_htm.xml XML 3480
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38560 | Film No.: 221259667
SIC: 2834 Pharmaceutical Preparations